72 related articles for article (PubMed ID: 26200374)
21. Waiting time for treatment of women with breast cancer in Podlaskie Voivodeship (Poland) in view of place of residence. A population study.
Maślach D; Krzyżak M; Szpak A; Owoc A; Bielska-Lasota M
Ann Agric Environ Med; 2013; 20(1):161-6. PubMed ID: 23540232
[TBL] [Abstract][Full Text] [Related]
22. [Factors associated with the timely treatment of women with breast cancer supported by a non-governmental organization in Bogotá, Colombia].
Sánchez G; Niño CG; Estupiñán C
Biomedica; 2015; 35(4):505-12. PubMed ID: 26844439
[TBL] [Abstract][Full Text] [Related]
23. Comparison of elapsed times from breast cancer detection to first adjuvant therapy in Nova Scotia in 1999/2000 and 2003/04.
Rayson D; Saint-Jacques N; Younis T; Meadows J; Dewar R
CMAJ; 2007 Jan; 176(3):327-32. PubMed ID: 17261829
[TBL] [Abstract][Full Text] [Related]
24. Delay in presentation of symptomatic referrals to a breast clinic: patient and system factors.
Nosarti C; Crayford T; Roberts JV; Elias E; McKenzie K; David AS
Br J Cancer; 2000 Feb; 82(3):742-8. PubMed ID: 10682692
[TBL] [Abstract][Full Text] [Related]
25. Stage at diagnosis and comorbidity influence breast cancer survival in First Nations women in Ontario, Canada.
Sheppard AJ; Chiarelli AM; Marrett LD; Nishri ED; Trudeau ME
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2160-7. PubMed ID: 21803843
[TBL] [Abstract][Full Text] [Related]
26. Regional disparities in breast cancer outcomes and the process of care.
Weber JJ; Kachare SD; Vohra NA; Fitzgerald TF; Wong JH
Am Surg; 2014 Jul; 80(7):669-74. PubMed ID: 24987898
[TBL] [Abstract][Full Text] [Related]
27. Analysing risk factors for poorer breast cancer outcomes in residents of lower socioeconomic areas of Australia.
Roder D; Zorbas HM; Kollias J; Pyke CM; Walters D; Campbell ID; Taylor C; Webster F
Aust Health Rev; 2014 May; 38(2):134-41. PubMed ID: 24709287
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with time-to-treatment initiation of breast cancer.
Jomar RT; Velasco NS; Mendes GLQ; Guimarães RM; Fonseca VAO; Meira KC
Cien Saude Colet; 2023 Jul; 28(7):2155-2164. PubMed ID: 37436327
[TBL] [Abstract][Full Text] [Related]
29. Delay in breast cancer diagnosis: a Brazilian cohort study.
Medeiros GC; Thuler LCS; Bergmann A
Public Health; 2019 Feb; 167():88-95. PubMed ID: 30641460
[TBL] [Abstract][Full Text] [Related]
30. Determinants of Lack of Access to Treatment for Women Diagnosed with Breast Cancer in Brazil.
Alves MNT; Monteiro MFV; Alves FT; Dos Santos Figueiredo FW
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805293
[TBL] [Abstract][Full Text] [Related]
31. Cervical Cancer Treatment Delays and Associated Factors in a Cohort of Women From a Developing Country.
Ferreira da Silva I; Ferreira da Silva I; Koifman RJ
J Glob Oncol; 2019 Jan; 5():1-11. PubMed ID: 30694738
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer: diagnosis-to-treatment waiting times for elderly women at a reference hospital of São Paulo, Brazil.
Souza CB; Fustinoni SM; Amorim MH; Zandonade E; Matos JC; Schirmer J
Cien Saude Colet; 2015 Dec; 20(12):3805-16. PubMed ID: 26691805
[TBL] [Abstract][Full Text] [Related]
33. [Analysis of delays in diagnosis and treatment of breast cancer patients at a public hospital].
Trufelli DC; Miranda Vda C; Santos MB; Fraile NM; Pecoroni PG; Gonzaga Sde F; Riechelmann R; Kaliks R; Del Giglio A
Rev Assoc Med Bras (1992); 2008; 54(1):72-6. PubMed ID: 18392490
[TBL] [Abstract][Full Text] [Related]
34. Provider delay in the diagnosis and initiation of definitive treatment for breast cancer patients.
Otieno ES; Micheni JN; Kimende SK; Mutai KK
East Afr Med J; 2010 Apr; 87(4):143-6. PubMed ID: 23057288
[TBL] [Abstract][Full Text] [Related]
35. Clinical pathways of breast cancer patients treated in the Federal District, Brazil.
Barros ÂF; Araújo JM; Murta-Nascimento C; Dias A
Rev Saude Publica; 2019 Jan; 53():14. PubMed ID: 30726495
[TBL] [Abstract][Full Text] [Related]
36. Healthcare delay in breast cancer patients: a case study in a low-density population region from Mexico.
Rangel-Méndez JA; Novelo-Tec JF; Sánchez-Cruz JF; Cedillo-Rivera R; Moo-Puc RE
Future Oncol; 2018 Aug; 14(20):2067-2082. PubMed ID: 30027752
[TBL] [Abstract][Full Text] [Related]
37. [Interval for access to treatment for breast cancer in the Federal District, Brazil].
Barros ÂF; Uemura G; de Macedo JL
Rev Bras Ginecol Obstet; 2013 Oct; 35(10):458-63. PubMed ID: 24337058
[TBL] [Abstract][Full Text] [Related]
38. [Sociodemographic and clinical factors associated with time to treatment for colorectal cancer in Brazil, 2006-2015].
Lima MAN; Villela DAM
Cad Saude Publica; 2021; 37(5):e00214919. PubMed ID: 34076098
[TBL] [Abstract][Full Text] [Related]
39. Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast Brazil.
Shafaee MN; Silva LR; Ramalho S; Doria MT; De Andrade Natal R; Cabello V; Cons L; Pavanello M; Zeferino LC; Mano MS; Linck RDM; Batista LS; Pedro EP; De Paula BH; Zuca-Matthes G; Podany E; Makawita S; Ann Stewart K; Tsavachidis S; Tamimi R; Bondy M; Debord L; Ellis M; Bines J; Cabello C
Oncologist; 2022 May; 27(5):344-351. PubMed ID: 35348756
[TBL] [Abstract][Full Text] [Related]
40. Delay in Diagnosis and Treatment of Breast Cancer among Women Attending a Reference Service in Brazil.
Romeiro Lopes TC; Gravena AAF; Demitto MO; Borghesan DHP; Dell`Agnolo CM; Brischiliari SCR; Carvalho MDB; Pelloso SM
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3017-3023. PubMed ID: 29172274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
